Author: Nesrine Merah

Scientists at IISc declare a promising new TB vaccine using OMVs

Abstract The researchers working on the novel vaccine are keeping their hopes high that it will be able to elicit an immunological response and provide protection against the disease. The novel vaccine has been developed in the hopes that it will stimulate an immunological response and provide protection against the disease. Using knowledge of OMV bio-genesis and their roles in bacterial virulence and pathogenesis, researchers have developed a new vaccine for tuberculosis that combines immunization with targeted medication delivery. The creation of the TB vaccine An experimental vaccination against tuberculosis has been produced by Rachit Agarwal, an assistant professor at…

Read More
cervical cancer

The Indian medical community is hopeful that the vaccine against cervical cancer will significantly improve survival rates. The Drugs Controller General of India (DCGI) has approved the first ‘Made in India’ quadrivalent Human Papilloma Virus (qHPV) vaccine, and its distribution has begun. This is excellent news for women, who will now be able to receive protection against cervical cancer, one of the most common diseases affecting women. Vaccination trials were conducted in 2018 across various cities in India. With the support of the Department of Biotechnology, SII was able to complete phase two and the requisite clinical trials, and now…

Read More